BG US  START  ZAAWANSOWANE SZUKANIE  SCHOWEK
BAZA PUBLIKACJI PRACOWNIKÓW US

A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor – 25I-NBOMe /

Daria Schetz, Adriana Schetz, Ivan Kocić.
Schetz, Daria.
Biomedicine & Pharmacotherapy
[online]
Article in press (accepted, peer reviewed, not yet assigned to volumes/issues, but is citable using).
Miejsce w dokumencie: 2022, [br. vol.], [br. s.]
Schetz, Adriana.

Publikacja dostępna w open access na licencji CC BY 4.0.

Received 21 August 2021, revised 30 September 2021, accepted 5 October 2021, available online 1 January 2022.
The data that support the findings of this study are available from the corresponding author upon reasonable request.
CRediT authorship contribution statement: Daria Schetz: conceptualization, methodology, formal analysis, resources, writing – original draft, writing – review & editing, visualization, project administration, Adriana Schetz: conceptualization, methodology, writing – review & editing, Ivan Kocić: methodology, writing – review & editing, project administration..

10.1016/j.biopha.2021.112295


hallucinogen persisting perception disorder
agonist of 5-HT2A25I-NBOMe
novel psychoactive substances

Rodzaj dokumentu:
Artykuł

https://www.sciencedirect.com/science/article/pii/S0753332221010799/pdfft?md5=b5b966dcd1f35f7c3697786c3358d2c6&pid=1-s2.0-S0753332221010799-main.pdf 

70071 (to nie jest sygnatura)